CoChat

Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes

Li, Jiangyan, Zhang, Jie, Li, Qian, Hu, Yue, Ruan, Yonghua, Tao, Zhiyong, Xia, Hui, Qiao, Jichen, Meng, Lingwen, Zeng, Weilin, Li, Cuiying, He, Xi, Zhao, Luyi, Siddiqui, Faiza A., Miao, Jun, Yang, Zhaoqing, Fang, Qiang, Cui, Liwang · 2020 · PLOS Neglected Tropical Diseases
Cited by 26

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pntd.0008255

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 68

  1. L Cui, 2018, Towards Malaria Elimination: A Leap Forward, 179
  2. JK Baird, 2017, Asia-Pacific malaria is singular, pervasive, diverse and invisible, International journal for parasitology, 47, 371, 10.1016/j.ijpara.2016.06.006 · DOI
  3. NM Anstey, 2009, The pathophysiology of vivax malaria, Trends Parasitol, 25, 220, 10.1016/j.pt.2009.02.003 · DOI · Paper page
  4. JK Baird, 2009, Resistance to therapies for infection by Plasmodium vivax, Clinical microbiology reviews, 22, 508, 10.1128/CMR.00008-09 · DOI · Paper page
  5. NM Douglas, 2010, Artemisinin combination therapy for vivax malaria, Lancet Infect Dis, 10, 405, 10.1016/S1473-3099(10)70079-7 · DOI · Paper page
  6. JK Baird, 2011, Resistance to chloroquine unhinges vivax malaria therapeutics, Antimicrobial agents and chemotherapy, 55, 1827, 10.1128/AAC.01296-10 · DOI
  7. KH Rieckmann, 1989, Plasmodium vivax resistance to chloroquine?, Lancet, 2, 1183, 10.1016/S0140-6736(89)91792-3 · DOI · Paper page
  8. JK Baird, 1991, Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia, The American journal of tropical medicine and hygiene, 44, 547, 10.4269/ajtmh.1991.44.547 · DOI · Paper page
  9. RN Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, The Lancet Infectious diseases, 14, 982, 10.1016/S1473-3099(14)70855-2 · DOI · Paper page
  10. H Liu, 2014, Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008–2013, Malaria journal, 13, 364, 10.1186/1475-2875-13-364 · DOI
  11. C Amaratunga, 2014, Chloroquine remains effective for treating Plasmodium vivax malaria in Pursat province, Western Cambodia, Antimicrob Agents Chemother, 58, 6270, 10.1128/AAC.03026-14 · doi:10.1128/aac.03026-14
  12. Myat-Phone-Kyaw, 1993, Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma), Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 687, 10.1016/0035-9203(93)90294-Z · DOI
  13. T Marlar, 1995, Development of resistance to chloroquine by Plasmodium vivax in Myanmar, Trans R Soc Trop Med Hyg, 89, 307, 10.1016/0035-9203(95)90556-1 · DOI
  14. JP Guthmann, 2008, Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar, Trop Med Int Health, 13, 91, 10.1111/j.1365-3156.2007.01978.x · DOI
  15. L Yuan, 2015, Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar, Antimicrob Agents Chemother, 59, 1230, 10.1128/AAC.04270-14 · DOI · Paper page
  16. MW Htun, 2017, Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow, Malaria journal, 16, 281, 10.1186/s12936-017-1912-y · DOI
  17. PV Thanh, 2015, Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam, Antimicrob Agents Chemother, 59, 7411, 10.1128/AAC.00791-15 · DOI
  18. RN Price, 2012, Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax, Trends in parasitology, 28, 522, 10.1016/j.pt.2012.08.005 · DOI
  19. RN Price, 2004, Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, Lancet, 364, 438, 10.1016/S0140-6736(04)16767-6 · DOI · Paper page
  20. MT Duraisingh, 2000, The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin, Mol Biochem Parasitol, 108, 13, 10.1016/S0166-6851(00)00201-2 · DOI · Paper page
  21. CT Happi, 2006, Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria, The American journal of tropical medicine and hygiene, 75, 155, 10.4269/ajtmh.2006.75.155 · doi:10.4269/ajtmh.2006.75.155
  22. A Djimde, 2001, Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria, Lancet, 358, 890, 10.1016/S0140-6736(01)06040-8 · DOI · Paper page
  23. R Suwanarusk, 2007, Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms, PloS one, 2, e1089, 10.1371/journal.pone.0001089 · DOI · Paper page
  24. C Barnadas, 2008, Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes, Antimicrobial agents and chemotherapy, 52, 4233, 10.1128/AAC.00578-08 · DOI
  25. JM Sa, 2005, Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains, Exp Parasitol, 109, 256, 10.1016/j.exppara.2004.12.005 · DOI
  26. LR Gomes, 2016, Plasmodium vivax mdr1 genotypes in isolates from successfully cured patients living in endemic and non-endemic Brazilian areas, Malaria journal, 15, 96, 10.1186/s12936-016-1141-9 · DOI · Paper page
  27. R Suwanarusk, 2008, Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax, J Infect Dis, 198, 1558, 10.1086/592451 · DOI · Paper page
  28. E Faway, 2016, Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana, Malar J, 15, 540, 10.1186/s12936-016-1595-9 · doi:10.1186/s12936-016-1595-9
  29. N Khim, 2014, Effects of mefloquine use on Plasmodium vivax multidrug resistance, Emerging infectious diseases, 20, 1637, 10.3201/eid2010.140411 · DOI
  30. GC Melo, 2014, Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon, PloS one, 9, e105922, 10.1371/journal.pone.0105922 · DOI · Paper page
  31. Z Pava, 2016, Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility, Antimicrob Agents Chemother, 60, 361, 10.1128/AAC.02207-15 · DOI
  32. H Noedl, 2008, Evidence of artemisinin-resistant malaria in western Cambodia, N Engl J Med, 359, 2619, 10.1056/NEJMc0805011 · DOI · Paper page
  33. C Amaratunga, 2014, Artemisinin resistance in Plasmodium falciparum, Lancet Infect Dis, 14, 449, 10.1016/S1473-3099(14)70777-7 · doi:10.1016/s1473-3099(14)70777-7
  34. G Holmgren, 2007, Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa, Infect Genet Evol, 7, 562, 10.1016/j.meegid.2007.03.005 · doi:10.1016/j.meegid.2007.03.005
  35. F Nawaz, 2009, Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda, J Infect Dis, 200, 1650, 10.1086/647988 · DOI
  36. Y Hu, 2016, Seasonal dynamics and microgeographical spatial heterogeneity of malaria along the China-Myanmar border, Acta tropica, 157, 12, 10.1016/j.actatropica.2016.01.022 · DOI
  37. G Zhou, 2016, Impact of interventions on malaria in internally displaced persons along the China-Myanmar border: 2011–2014, Malaria journal, 15, 471, 10.1186/s12936-016-1512-2 · DOI
  38. J Geng, 2019, Increasing trends of malaria in a border area of the Greater Mekong Subregion, Malaria journal, 18, 309, 10.1186/s12936-019-2924-6 · DOI
  39. G Zhou, 2014, Clinical malaria along the China-Myanmar border, Yunnan Province, China, January 2011-August 2012, Emerging infectious diseases, 20, 675, 10.3201/eid2004.130647 · DOI
  40. F Lu, 2017, Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China, Parasit Vectors, 10, 355, 10.1186/s13071-017-2298-y · DOI
  41. D Wang, 2015, Transmission Risk from Imported Plasmodium vivax Malaria in the China-Myanmar Border Region, Emerg Infect Dis, 21, 1861, 10.3201/eid2110.150679 · DOI
  42. SP Johnston, 2006, PCR as a confirmatory technique for laboratory diagnosis of malaria, Journal of clinical microbiology, 44, 1087, 10.1128/JCM.44.3.1087-1089.2006 · DOI · Paper page
  43. MC Bruce, 1999, Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity, The American journal of tropical medicine and hygiene, 61, 518, 10.4269/ajtmh.1999.61.518 · DOI
  44. BM Russell, 2003, Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic, Antimicrobial agents and chemotherapy, 47, 170, 10.1128/AAC.47.1.170-173.2003 · DOI
  45. J Li, 2017, Further evaluation of the NWF filter for the purification of Plasmodium vivax-infected erythrocytes, Malar J, 16, 201, 10.1186/s12936-017-1855-3 · DOI
  46. ZY Tao, 2011, Development and evaluation of a prototype non-woven fabric filter for purification of malaria-infected blood, Malar J, 10, 251, 10.1186/1475-2875-10-251 · doi:10.1186/1475-2875-10-251
  47. J Marfurt, 2012, Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax, Antimicrobial agents and chemotherapy, 56, 5258, 10.1128/AAC.00283-12 · DOI
  48. F Lu, 2012, Prevalence of drug resistance-associated gene mutations in Plasmodium vivax in Central China, Korean J Parasitol, 50, 379, 10.3347/kjp.2012.50.4.379 · DOI
  49. MW Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res, 29, e45, 10.1093/nar/29.9.e45 · DOI · Paper page
  50. S Brega, 2005, Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity, J Infect Dis, 191, 272, 10.1086/426830 · DOI
  51. F Lu, 2011, In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China, The American journal of tropical medicine and hygiene, 85, 197, 10.4269/ajtmh.2011.10-0070 · doi:10.4269/ajtmh.2011.10-0070
  52. JK Baird, 2016, Diagnosis and Treatment of Plasmodium vivax Malaria, The American journal of tropical medicine and hygiene, 95, 35, 10.4269/ajtmh.16-0171 · DOI
  53. RD Cooper, 1994, Studies of a chloroquine-resistant strain of Plasmodium vivax from Papua New Guinea in Aotus and Anopheles farauti s.l, J Parasitol, 80, 789, 10.2307/3283259 · doi:10.2307/3283259
  54. RK Singh, 2000, Emergence of chloroquine-resistant vivax malaria in south Bihar (India), Trans R Soc Trop Med Hyg, 94, 327, 10.1016/S0035-9203(00)90344-4 · DOI · Paper page
  55. S Shalini, 2014, Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India, Malar J, 13, 129, 10.1186/1475-2875-13-129 · DOI
  56. AT Bright, 2014, A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings, PLoS Negl Trop Dis, 8, e2882, 10.1371/journal.pntd.0002882 · DOI · Paper page
  57. MH Nyunt, 2017, Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009–2016), Malar J, 16, 117, 10.1186/s12936-017-1770-7 · doi:10.1186/s12936-017-1770-7
  58. E Tjitra, 2008, Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia, PLoS Med, 5, e128, 10.1371/journal.pmed.0050128 · DOI · Paper page
  59. K Chotivanich, 2009, Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea, The American journal of tropical medicine and hygiene, 80, 902, 10.4269/ajtmh.2009.80.902 · DOI
  60. D Fernandez, 2014, In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia, Antimicrob Agents Chemother, 58, 6354, 10.1128/AAC.03191-14 · DOI
  61. K Rungsihirunrat, 2015, Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand, Korean J Parasitol, 53, 43, 10.3347/kjp.2015.53.1.43 · DOI
  62. B Witkowski, 2013, Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies, The Lancet Infectious diseases, 13, 1043, 10.1016/S1473-3099(13)70252-4 · DOI · Paper page
  63. J Zhang, 2017, Overview of the improvement of the ring-stage survival assay-a novel phenotypic assay for the detection of artemisinin-resistant Plasmodium falciparum, Zoological research, 38, 317
  64. YF Chehuan, 2013, In vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian Amazon, Malar J, 12, 226, 10.1186/1475-2875-12-226 · DOI · Paper page
  65. K Tantiamornkul, 2018, The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014, International journal for parasitology Drugs and drug resistance, 8, 229, 10.1016/j.ijpddr.2018.04.003 · DOI
  66. M Imwong, 2008, Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar, Antimicrob Agents Chemother, 52, 2657, 10.1128/AAC.01459-07 · doi:10.1128/aac.01459-07
  67. H Meng, 2010, In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger, Antimicrob Agents Chemother, 54, 4306, 10.1128/AAC.00321-10 · DOI
  68. S Joy, 2018, Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India, Malar J, 17, 40, 10.1186/s12936-018-2188-6 · DOI

Cited by

Metadata

Authors
Li, J., Zhang, J., Li, Q., Hu, Y., Ruan, Y., Tao, Z., Xia, H., Qiao, J., Meng, L., Zeng, W., Li, C., He, X., Zhao, L., Siddiqui, F. A., Miao, J., Yang, Z., Fang, Q., & Cui, L.
Venue
PLOS Neglected Tropical Diseases
Published
2020-06-12
Volume
14
Issue
6
Pages
e0008255
ISSN
1935-2735
Cited by
26
References
5
Language
en
Funders
  • Foundation for the National Institutes of Health (U19 AI089672)
  • Scientific Research Innovation Team Project of Anhui Colleges and Universities (2016-40)
  • Training Project for Provincial Academic Technology Leaders in Anhui Colleges and Universities (2014053)
  • Anhui Provincial Natural Science Foundation (No. 1308085MH160)
  • National Natural Science Foundation of China (31860604, U1802286)
  • Major science and technology projects of Yunnan (2018ZF0081)
  • Yunnan Applied Basic Research Projects-Union Foundation (2017FE468-185)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.